Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aveanna Healthcare Holdings Inc. (AVAH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aveanna, a diversified home care platform headquartered in Atlanta, Georgia with locations in 38 states, uses these filings to report material events, financing arrangements, and financial results related to its pediatric and adult home-based healthcare services.
Among the key documents available are Current Reports on Form 8-K, where Aveanna describes material definitive agreements such as amendments to its first lien credit agreement, the creation and refinancing of term loan and revolving credit facilities, and the termination of a second lien credit agreement. Other 8-K filings report underwriting agreements for secondary offerings of common stock by existing stockholders, as well as the closing of those offerings.
Aveanna also uses Form 8-K to furnish press releases announcing quarterly and year-to-date financial results, preliminary financial data, and updated guidance. These filings often discuss non-GAAP measures such as EBITDA, Adjusted EBITDA, Normalized Adjusted EBITDA, Field contribution, Field contribution margin, Adjusted net income, and Adjusted net income per diluted share, along with reconciliations to GAAP metrics. Additional 8-K items address board and governance matters, including amendments to stockholders’ agreements and changes in board composition.
On Stock Titan, users can view these AVAH filings alongside AI-powered summaries that explain the main points of each document in plain language. Real-time updates from EDGAR help surface new 8-Ks and, when filed, periodic reports such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. The platform also highlights insider-related filings like Form 4 when available, allowing investors to review reported transactions by directors and officers in the context of Aveanna’s broader regulatory and financial disclosures.
Form 4 filing for Aveanna Healthcare Holdings (AVAH) dated 07/10/2025 discloses ownership changes by 10% owner J.H. Whitney Equity Partners VII, LLC and its affiliated funds.
- No shares are now held directly by the reporting person; all ownership is indirect.
- Indirect holdings remain substantial: 28,890,756 shares via J.H. Whitney VII, L.P.; 15,523,809 shares via PSA Healthcare Investment Holdings LLC; and 1,426,034 shares via PSA Iliad Holdings LLC.
- Two transactions coded “J” (other, no consideration) were recorded on 07/10/2025: in-kind distributions of 64,773 shares from PSA Healthcare and 17,109 shares from PSA Iliad Holdings to their respective members at a price of $0.
- The filing states these distributions were purely structural; the reporting entities disclaim beneficial ownership beyond their economic interest.
No derivative securities were involved and no purchase or sale for cash occurred. The overall economic exposure of the reporting group declined by only 81,882 shares (<0.2% of their prior holding), suggesting a minor internal reallocation rather than a traditional insider sale.
Form 4 highlights: On 07/10/2025, Paul R. Vigano, a 10% owner of Aveanna Healthcare Holdings (AVAH), reported two in-kind distributions of common stock from investment vehicles he oversees.
- 64,773 shares were distributed out of PSA Healthcare Investment Holdings LLC.
- 17,109 shares were distributed out of PSA Iliad Holdings LLC.
The transactions were coded “J,” indicating bona-fide gifts or distributions at a reported price of $0. Post-transaction, Vigano continues to hold a large indirect stake:
- 28.9 million shares via J.H. Whitney VII, L.P.
- 15.5 million shares via PSA Healthcare
- 5.18 million shares via JHW Iliad Holdings LLC
- 1.43 million shares via PSA Iliad Holdings LLC
- 0.54 million shares via JHW Iliad Holdings II LLC
The 81,882-share reduction represents <0.2% of Vigano’s reported indirect ownership and does not involve open-market sales or cash proceeds. No derivative securities were listed. Given the minimal size relative to his overall position, the filing appears neutral in investment significance.
Form 4 filing overview: Robert M. Williams Jr., identified as a 10% owner of Aveanna Healthcare Holdings, Inc. (AVAH), reported two immaterial transactions dated 07/10/2025. Both were coded “J,” indicating in-kind distributions rather than open-market trades.
- PSA Healthcare Investment Holdings LLC distributed 64,773 AVAH common shares to its members at a stated price of $0, reducing its post-distribution position to 15,523,809 shares.
- PSA Iliad Holdings LLC similarly distributed 17,109 shares, leaving 1,426,034 shares.
No purchases were reported, and the filing shows Mr. Williams continues to hold—through multiple J.H. Whitney-related entities—approximately 51.6 million shares indirectly. There were no direct holdings and no change to the larger positions held by J.H. Whitney VII, L.P. (28.9 million shares), JHW Iliad Holdings LLC (5.18 million), or JHW Iliad Holdings II LLC (0.54 million).
Investor takeaway: The reported movements are administrative re-allocations within affiliated funds, executed at $0 and representing less than 0.2% of the insider’s aggregate indirect stake. Because no cash sales occurred and overall exposure remains essentially unchanged, the filing is neutral from a supply-demand perspective but does increase the free-float slightly as distributed shares migrate to individual members.
Aveanna Healthcare (NASDAQ: AVAH) filed an 8-K announcing a Seventh Amendment to its receivables securitization facility. The amendment raises the maximum availability to $275 million, subject to the existing borrowing-base, and extends the scheduled termination date to three years from 25 June 2025. The change strengthens near-term liquidity and pushes out maturities without adding new restrictive covenants. The full text of the amendment is filed as Exhibit 10.1.